tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ABOS Stock Latest News

Acumen Pharmaceuticals’ Earnings Call: Progress Amid Challenges
Company AnnouncementsAcumen Pharmaceuticals’ Earnings Call: Progress Amid Challenges
3d ago
ABOS
Acumen Pharmaceuticals’ Promising Alzheimer’s Strategy Earns Buy Rating with Revised Price Target
PremiumRatings
Acumen Pharmaceuticals’ Promising Alzheimer’s Strategy Earns Buy Rating with Revised Price Target
3d ago
ABOS
Acumen price target lowered to $11 from $15 at H.C. Wainwright
PremiumThe Fly
Acumen price target lowered to $11 from $15 at H.C. Wainwright
3d ago
ABOS
Acumen price target lowered to $10 from $12 at BofA
PremiumThe Fly
Acumen price target lowered to $10 from $12 at BofA
3d ago
ABOS
Acumen price target lowered to $4 from $6 at UBS
PremiumThe Fly
Acumen price target lowered to $4 from $6 at UBS
3d ago
ABOS
Acumen Pharmaceuticals Advances Alzheimer’s Treatment Efforts
PremiumCompany AnnouncementsAcumen Pharmaceuticals Advances Alzheimer’s Treatment Efforts
3d ago
ABOS
Acumen Pharmaceuticals Completes Enrollment for Phase 2 Study
Premium
Company Announcements
Acumen Pharmaceuticals Completes Enrollment for Phase 2 Study
4d ago
8K
ABOS
Acumen reports FY24 EPS ($1.71), consensus ($1.32)
Premium
The Fly
Acumen reports FY24 EPS ($1.71), consensus ($1.32)
4d ago
ABOS
Acumen sees cash runway into 1H27
PremiumThe Fly
Acumen sees cash runway into 1H27
4d ago
ABOS
Acumen expects topline results from ALTITUDE-AD in late 2026
PremiumThe Fly
Acumen expects topline results from ALTITUDE-AD in late 2026
4d ago
ABOS
Acumen completes enrollment of ALTITUDE-AD Phase 2 trial
PremiumThe Fly
Acumen completes enrollment of ALTITUDE-AD Phase 2 trial
5d ago
ABOS
Acumen announces results from Phase 1 study of sabirnetug in volunteers
PremiumThe Fly
Acumen announces results from Phase 1 study of sabirnetug in volunteers
12d ago
ABOS
Acumen announces Phase 1 INTERCEPT-AD study publication
PremiumThe FlyAcumen announces Phase 1 INTERCEPT-AD study publication
3M ago
ABOS
Acumen Pharmaceuticals Advances Alzheimer’s Therapeutic
Premium
Company Announcements
Acumen Pharmaceuticals Advances Alzheimer’s Therapeutic
5M ago
ABOS
Acumen Pharma Reports Q3 2024, Highlights Alzheimer’s Focus
Premium
Company Announcements
Acumen Pharma Reports Q3 2024, Highlights Alzheimer’s Focus
5M ago
8K
ABOS
Acumen reports Q3 EPS (50c), consensus (36c)
PremiumThe Fly
Acumen reports Q3 EPS (50c), consensus (36c)
5M ago
ABOS
ABOS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ABOS Earnings this Week: How Will it Perform?
5M ago
ABOS
Acumen appoints Schacterle as Chief Regulatory Officer, Head of Quality
PremiumThe Fly
Acumen appoints Schacterle as Chief Regulatory Officer, Head of Quality
5M ago
ABOS
SAGE
Acumen presents data on pTau217 assay to screen for Phase 2 ALTITUDE-AD trial
PremiumThe Fly
Acumen presents data on pTau217 assay to screen for Phase 2 ALTITUDE-AD trial
5M ago
ABOS
Acumen to deliver late-breaking presentation on ACU193 at CTAD conference
PremiumThe FlyAcumen to deliver late-breaking presentation on ACU193 at CTAD conference
5M ago
ABOS
Acumen extends collaboration with Lonza
Premium
The Fly
Acumen extends collaboration with Lonza
6M ago
ABOS
Acumen Pharmaceuticals Unveils Updated Corporate Presentation and Financials
Premium
Company Announcements
Acumen Pharmaceuticals Unveils Updated Corporate Presentation and Financials
8M ago
8K
ABOS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >